Prostate Cancer Reports


Volume 1 Number 4
 April 2013

Home > Prostate Cancer Reports > Volume 1 - Year 2013 > Number 4, April 2013

CONTENTS


Clinical Investigations
Active surveillance
Recurrent prostate cancer
Localized prostate cancer


CLINICAL INVESTIGATIONS


Cholesterol

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.
Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Abstract | Related citations


Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA.
Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.
Ann Oncol. 2013 Mar 18. [Epub ahead of print]
Abstract | Full text | Related citations


Functional outcomes

Ficarra V, Borghesi M, Suardi N, De Naeyer G, Novara G, Schatteman P, De Groote R, Carpentier P, Mottrie A.
Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
BJU Int. 2013 Mar 7. doi: 10.1111/bju.12001. [Epub ahead of print]
Abstract | Related citations


Gleason scoring system

Kim KH, Lim SK, Shin TY, Lee JY, Chung BH, Rha KH, Hong SJ.
Upgrading of Gleason score and prostate volume: a clinicopathological analysis.
BJU Int. 2013 Mar 4. doi: 10.1111/j.1464-410X.2013.11799.x. [Epub ahead of print]
Abstract | Related citations


Pierorazio PM, Walsh PC, Partin AW, Epstein JI.
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.
BJU Int. 2013 May;111(5):753-60. doi: 10.1111/j.1464-410X.2012.11611.x. Epub 2013 Mar 6.
Abstract | Full text | Related citations


Hyperglycemia

Wright JL, Plymate SR, Porter MP, Gore JL, Lin DW, Hu E, Zeliadt SB.
Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer.
Prostate Cancer Prostatic Dis. 2013 Mar 5. doi: 10.1038/pcan.2013.5. [Epub ahead of print]
Abstract | Related citations


Lymph node dissection

Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Passoni N, Fossati N, Sun M, Dell'oglio P, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A.
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center.
Ann Oncol. 2013 Mar 18. [Epub ahead of print]
Abstract | Related citations


Obesity

Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB.
Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
Urology. 2013 May;81(5):992-7. doi: 10.1016/j.urology.2012.10.080. Epub 2013 Feb 28.
Abstract | Related citations


Risk and mortality

Bourgade V, Drouin SJ, Yates DR, Parra J, Bitker MO, Cussenot O, RouprÍt M.
Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
World J Urol. 2013 Mar 2. [Epub ahead of print]
Abstract | Related citations


Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL 3rd, Strope SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Kibel AS.
Mortality After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity.
Eur Urol. 2013 Mar 13. doi:pii: S0302-2838(13)00229-7. 10.1016/j.eururo.2013.03.005. [Epub ahead of print]
Abstract | Full text | Related citations


van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M, Vickers A, van der Poel HG.
Timing of Curative Treatment for Prostate Cancer: A Systematic Review.
Eur Urol. 2013 Feb 22. doi:pii: S0302-2838(13)00136-X. 10.1016/j.eururo.2013.02.024. [Epub ahead of print]
Abstract | Related citations


RARP

Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR.
How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
BJU Int. 2013 Mar 4. doi: 10.1111/j.1464-410X.2012.11493.x. [Epub ahead of print]
Abstract | Related citations

ACTIVE SURVEILLANCE


Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A, Huddart RA, Dearnaley DP, Parker CC.
Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer.
Eur Urol. 2013 Feb 18. doi:pii: S0302-2838(13)00132-2. 10.1016/j.eururo.2013.02.020. [Epub ahead of print]
Abstract | Related citations

RECURRENT PROSTATE CANCER


Abdollah F, Boorjian S, Cozzarini C, Suardi N, Sun M, Fiorino C, di Muzio N, Karakiewicz PI, Montorsi F, Karnes RJ, Briganti A.
Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient Stratification.
Eur Urol. 2013 Mar 13. doi:pii: S0302-2838(13)00230-3. 10.1016/j.eururo.2013.03.006. [Epub ahead of print]
Abstract | Related citations


Evangelista L, Zattoni F, Guttilla A, Saladini G, Zattoni F, Colletti PM, Rubello D.
Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer: A Systematic Review and Meta-Analysis.
Clin Nucl Med. 2013 May;38(5):305-14. doi: 10.1097/RLU.0b013e3182867f3c.
Abstract | Related citations


GarcŪa JR, Ponce A, Canales M, Ayuso J, Moragas M, Soler M.
[Detection of second tumors in 11C-choline PET/CT studies performed due to biochemical recurrence of prostate cancer.]
Rev Esp Med Nucl Imagen Mol. 2013 Mar 13. doi:pii: S2253-654X(13)00010-3. 10.1016/j.remn.2013.01.007. [Epub ahead of print] Spanish.
Abstract | Related citations


Nakabayashi M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh W, Morganstern DE, Kantoff PW, Taplin ME.
Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.
Urology. 2013 Mar;81(3):611-6. doi: 10.1016/j.urology.2012.12.025.
Abstract | Related citations


Schiavina R, Borghesi M, Fiorentino M, Brunocilla E, Manferrari F, Vagnoni V, Martorana G.
Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score.
Int J Urol. 2013 Mar 21. doi: 10.1111/iju.12124. [Epub ahead of print]
Abstract | Related citations


Yamamoto S.
Editorial Comment from Dr Yamamoto to Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score.
Int J Urol. 2013 Mar 21. doi: 10.1111/iju.12134. [Epub ahead of print]
Abstract | Full text | Related citations


Yeung VH, Chiu Y, Yu SS, Au WH, Chan SW.
Are preoperative kattan and stephenson nomograms predicting biochemical recurrence after radical prostatectomy applicable in the chinese population?
ScientificWorldJournal. 2013;2013:506062. doi: 10.1155/2013/506062. Epub 2013 Mar 5.
Abstract | Full text | Related citations

LOCALIZED PROSTATE CANCER


Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience.
Radiat Oncol. 2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.
Abstract | Full text | Related citations


Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C.
Prostate cancer: how do patients choose their treatment?
Bull Cancer. 2013 Mar 1;100(3):191-199.
Abstract | Related citations



RÝder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H, Carlsson S, Jakobsen H, Borre M, Iversen P.
Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study.
BJU Int. 2013 Mar 15. doi: 10.1111/bju.12065. [Epub ahead of print]
Abstract | Related citations